Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid

Abstract

We investigate common pathophysiology in paediatric and adult multiple sclerosis (MS) by comparison of cerebrospinal fluid (CSF) data. We compared cerebrospinal fluid (CSF) data from eight patient groups with onset of MS at 7 to 29 years (n = 184). A new statistics program allows sensitive detection, quantifies the mean amount of intrathecal Ig synthesis in groups based on the 96% reference range of 4100 non-inflammatory controls, corrects for age-related increase of blood-derived albumin and immunoglobulins in CSF, and presents graphical data interpretation in Reibergrams. Already at onset of MS before puberty (≤10 years) the frequency of intrathecal IgG synthesis (oligoclonal IgG) was 100% like in adults with 98%, but the amount of intrathecal IgG increases twofold during puberty. Intrathecal IgM synthesis is most frequent before and during puberty (in 57—67% of patients) compared with 41% in adults. The amount of intrathecal IgM synthesis before puberty is only 30% of that in adults. IgG and IgM Index are biased evaluations not suitable for characterizing age-related dynamics. A twofold age-related increase of the albumin quotient, Q_Alb, as a measure of the blood—CSF barrier function, represents normal physiological growth. Cell counts in CSF are low. The pre-puberty gender ratio is about 1:1. Intrathecal antibodies against measles, rubella and/or varicella zoster virus are detected in 73% of patients before puberty compared with 89% of adults. Individual paediatric patients (n = 17), with sequential punctures over 2—5 years, show constant quantities of intrathecal IgM and specific antibodies. In conclusion, paediatric MS already at first clinical manifestation shows the complete, neuroimmunological data pattern in CSF, i.e. inflammatory signs are not gradually evolving. Paediatric and adult MS differ quantitatively but not qualitatively in neuroimmunological patterns which does not allow for discrimination between ‘early’ and ‘late’ onset MS. CSF analysis may help to discriminate between acute and mono-symptomatic chronic inflammatory disease already at earliest clinical manifestation.

Keywords

paediatric multiple sclerosis puberty cerebrospinal fluid IgG IgA IgM intrathecal synthesis statistics measles rubella varicella zoster antibody index IgG index

Get full access to this article

View all access options for this article.

References

Duquette P. , Murray TJ , Pleines J. , et al. Multiple sclerosis in childhood: Clinical profile in 125 patients . J Pediatr 1987; 111: 359-363.

Hanefeld F. Characteristics of childhood multiple sclerosis . Int MS J 1994; 1: 91-97.

Hanefeld F. Pediatric multiple sclerosis. A short history of a long story. Neurology 2007; 68: 3-6.

Bachmann S. , Kesselring J. Multiple sclerosis and infectious childhood diseases. Neuroepidemiology 1998; 17: 154-160.

Reiber H. , Ungefehr ST , Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Multiple Sclerosis 1998; 4: 111-117.

Reiber H. , Peter JB Cerebrospinal fluid analysis-disease-related data patterns and evaluation programs. J Neurol Sci 2001; 184: 101-122.

Reiber H. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998; 4: 99-107.

Reiber H. , Albaum W. Statistical evaluation of intrathecal protein synthesis in CSF/Serum quotient diagrams. Acta Neuropsychiatrica 2008; 20(Suppl 1): 48-49. (Free download of CSF Statistics Tool from http://www.COMEDcom.de).

Sindic CJM , Van Antwerp MP , Goffette S. The intrathecal humoral immune response: laboratory analysis and clinical relevance. Clin Chem Lab Med 2001; 39: 333-340.

10.

Andersson M. , Alvarez-Cermeño J. , Bernardi G. , et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatr 1994; 57: 897-902.

11.

Freedman MS , Thompson EJ , Deisenhammer F. , et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. A consensus statement . Arch Neurol 2005; 62: 865-870.

12.

Sharief MK , Thompson EJ Intrathecal immunoglobulin M synthesis in multiple sclerosis. Brain 1991; 114: 181-195.

13.

Villar LM , Masjuan J. , Gonzalez-Porque P. , et al. Intrathecal IgM synthesis is a prognostic factor in Multiple sclerosis. Ann Neurol 2003; 53: 222-226.

14.

Reiber H. Flow rate of cerebrospinal fluid (CSF)-a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994; 122: 189-203.

15.

Reiber H. Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 2003; 21: 79-96.

16.

Felgenhauer K. , Schaedlich H. , Nekic M. , Ackermann R. Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis. J Neurol Sci 1985; 71: 292-299. 17. Sindic CJM , Monteyne P. , Laterre E. The intrathecal synthesis of virus specific oligoclonal IgG in MS. J NeuroImmunol 1994; 46: 75-80.

17.

Reiber H. , Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain . Clin Chem 1991; 37: 1153-1160.

18.

Quentin CD , Reiber H. Fuchs’ Heterochromic Cyclitis-rubella virus antibodies and genome in aqueous humor. AJO 2004; 138: 46-54.

19.

Graef IT , Henze T. , Reiber H. Polyspezifische Immunreaktion im ZNS bei Auto-immunerkrankungen mit ZNS-Beteiligung . Z ärztliche Fortbildung 1994; 88: 587-591.

20.

Stachan-Kunstyr R. , Wagner D. , Wurster U. Occurrence of virus antigenspecific antibodies in neurological diseases. Akt Neurol 1996; 23: 66.

21.

Pohl D. , Hennemuth I. , Kries R. , Hanefeld F. Paediatric multiple sclerosis and ADEM in Germany: results of a nationwide survey. Eur J Pediatr 2007; 166: 405-412.

22.

Poser CM , Brinar VV Disseminated encephalomyelitis and multiple sclerosis: two different diseases-a critical review. Acta Neurol Scand 2007; 116: 201-206.

23.

Stauch C. , Rauchenzauner M. , Pohl D. , Hanefeld F. , Reiber H. , Rostásy KM Intrathecal IgM synthesis in children with multiple sclerosis is associated with a slower progression. Acta Neurol 2009 ; submitted.

24.

McDonald WI , Compston A. , Edan G. , et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.

25.

Wildemann B. , Reiber H. , Oschmann P. Laboratory diagnosis in neurology. Thieme, 2009.

26.

Bechter K. , Reiber H. , Herzog S. , Fuchs D. , Tumani H. , Maxeiner HG Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood-CSF barrier dysfunction . J Psychiatric Research 2009, in press, doi 10.1016/j.jpsychires.2009.08.008.

27.

Jacobi C. , Lange P. , Reiber H. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: Discrimination between microorganism-driven and polyspecific immune response . J Neuroimmunol 2007; 187: 139-146.

28.

Pohl D. , Rostasy K. , Reiber H. , Hanefeld F. CSF characteristic in early onset multiple sclerosis. Neurology 2004; 63: 1966-1967.

29.

Reiber H. , Kruse-Sauter H. , Quentin CD Local variability of B-cell dependent immune response in aqueous humor and cerebrospinal fluid of the individual multiple sclerosis patient. J Neuroimmunol 2009; submitted.

30.

Adams JM , Imagawa DT Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 1962; 111: 562.

31.

Vartdal F. , Vandvik B. , Norrby E. Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 1980; 8: 248-255.

32.

Bloomer LC , et al. Epstein-Barr-Virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983; 40: 406-408.

33.

Johnson TJ The virology of demyelinating disease. Ann Neurol 1994; 36: 54-60.

34.

Soldan SS , Jacobson S. Role of viruses in etiology and pathogenesis in multiple sclerosis . Adv Virus Res 2001; 56: 513-551.

35.

Gilden DH , Devlin ME , Burgoon MP , Owens GP The search for virus in multiple sclerosis brain. Mult Scler 1996; 2: 179-183.

36.

Godec MS , Asher DM , Murray RS , et al. Absence of measles, mumps and rubella viral genome sequences from MS brain tissue by polymerase chain reaction. Ann Neurol 1992; 32: 401-404.

37.

Rostasy K. , Reiber H. , Pohl D. , et al. Chlamydia pneumoniae in children with MS: Frequency and quantity of intrathecal antibodies. Neurology 2003; 61: 125-128.

38.

Robinson-Agramonte M. , Reiber H. , Cabrera-Gomez JA , Galvizu R. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients. Acta Neurol Scand 2007; 115: 312-318.

39.

Bloomer LC , Salmon VC Epstein-Barr-Virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983; 40: 406-408.

40.

Conrad AJ , Chiang EY , Andeen LE , et al. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 1994; 54: 99-108.